$201.5 Million
New Amsterdam Pharma N.V.
New Amsterdam Pharma N.V.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$1.1 Billion
Applovin
Applovin
Confidentially Marketed Follow-On Offering
Passive Bookrunner
$100.0 Million
Ventyx Biosciences
Ventyx Biosciences
PIPE
Joint Placement Agent
$40.0 Million
Skye Bioscience
Skye Bioscience
PIPE
Sole Placement Agent
$50.0 Million
Unicycive
Unicycive Therapeutics
PIPE
Joint Placement Agent
$75.0 Million
Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$600.0 Million
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$200.0 Million
Praxis Precision Medicines
Praxis Precision Medicines, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$30.5 Million
Eagle Point Income Company Inc.
Eagle Point Income Company, Inc.
Series C Term Preferred
Active Bookrunner
$100.0 Million
Boundless Bio, Inc.
Boundless Bio, Inc.
Initial Public Offering
Active Bookrunner
Subscribe to Equity Capital Markets

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.